$BPTH
BIO-PATH HOLDINGS, INC.

2014 Q3 Form 10-Q Financial Statement

#000114420414050058 Filed on August 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2013 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $710.0K $750.0K $240.0K
YoY Change -12.35% 212.5% -4.0%
% of Gross Profit
Research & Development $424.5K $517.0K $156.0K
YoY Change -25.34% 231.36% -17.88%
% of Gross Profit
Depreciation & Amortization $40.00K $40.00K $40.00K
YoY Change 0.0% 0.0% -20.0%
% of Gross Profit
Operating Expenses $1.154M $1.275M $428.6K
YoY Change -17.19% 197.4% -45.59%
Operating Profit -$1.154M -$1.275M -$428.6K
YoY Change -17.19% 197.4% -45.59%
Interest Expense $10.00K $10.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $5.699K $6.024K $1.402K
YoY Change 993.86% 329.67% -2603.57%
Pretax Income -$1.150M -$1.270M -$430.0K
YoY Change -17.27% 195.35% -45.57%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.148M -$1.269M -$427.2K
YoY Change -17.57% 196.97% -45.77%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.556M -$2.822M -$1.303M
COMMON SHARES
Basic Shares Outstanding 89.24M shares 89.24M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q3 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.64M $15.72M $1.930M
YoY Change 257.07% 714.51% 1106.25%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $290.0K $171.6K $46.41K
YoY Change 45.0% 269.66% -0.17%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $14.93M $16.03M $2.253M
YoY Change 247.21% 611.73% 346.63%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $1.291M $1.331M $1.492M
YoY Change -10.77% -10.17%
Long-Term Investments
YoY Change
Other Assets $70.00K
YoY Change
Total Long-Term Assets $66.12K $1.331M $1.492M
YoY Change -95.44% -10.77% -10.17%
TOTAL ASSETS
Total Short-Term Assets $14.93M $16.03M $2.253M
Total Long-Term Assets $66.12K $1.331M $1.492M
Total Assets $16.28M $17.37M $3.745M
YoY Change 183.21% 363.74% 72.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $88.51K $78.92K $165.9K
YoY Change 121.29% -52.43% 432.63%
Accrued Expenses $190.0K $149.3K $4.892K
YoY Change 46.15% 2952.76% -94.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $280.0K $333.5K $267.9K
YoY Change 64.71% 24.51% 10.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $280.0K $333.5K $267.9K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $280.0K $333.5K $267.9K
YoY Change 64.71% 24.51% 10.22%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $89.24K $75.38K
YoY Change 18.38% 28.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.00M $17.03M $3.477M
YoY Change
Total Liabilities & Shareholders Equity $16.28M $17.37M $3.745M
YoY Change 183.21% 363.74% 72.95%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$1.148M -$1.269M -$427.2K
YoY Change -17.57% 196.97% -45.77%
Depreciation, Depletion And Amortization $40.00K $40.00K $40.00K
YoY Change 0.0% 0.0% -20.0%
Cash From Operating Activities -$1.020M -$1.100M -$570.0K
YoY Change 41.67% 92.98% -9.52%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$70.00K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 2.210M
YoY Change -100.0% -100.0% 952.38%
NET CHANGE
Cash From Operating Activities -1.020M -1.100M -570.0K
Cash From Investing Activities -70.00K 0.000 0.000
Cash From Financing Activities 0.000 0.000 2.210M
Net Change In Cash -1.090M -1.100M 1.640M
YoY Change -150.46% -167.07% -490.48%
FREE CASH FLOW
Cash From Operating Activities -$1.020M -$1.100M -$570.0K
Capital Expenditures -$70.00K $0.00 $0.00
Free Cash Flow -$950.0K -$1.100M -$570.0K
YoY Change 31.94% 92.98% -9.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 bpth Accrued Liabilities Related Parties Current
AccruedLiabilitiesRelatedPartiesCurrent
52050 USD
CY2013Q4 bpth Accrued Liabilities Related Parties Current
AccruedLiabilitiesRelatedPartiesCurrent
52050 USD
CY2014Q2 us-gaap Liabilities
Liabilities
333519 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
16034036 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
3667313 USD
CY2014Q2 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500374 USD
CY2013Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500374 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1169168 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1088856 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1331206 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1411518 USD
CY2014Q2 us-gaap Assets
Assets
17365242 USD
CY2011 bpth Percentage Of Change In Depreciation Amortization Of Intangible Assets And Asset Impairment And Other Charges Operating
PercentageOfChangeInDepreciationAmortizationOfIntangibleAssetsAndAssetImpairmentAndOtherChargesOperating
0.5 pure
CY2012Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
345000 USD
CY2014Q2 us-gaap Cash
Cash
15721128 USD
CY2013Q4 bpth Authorised Capital To Be Raised
AuthorisedCapitalToBeRaised
100000000 USD
CY2014Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15000000 USD
CY2014Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
13800000 USD
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
50000 USD
CY2014Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
3213 USD
CY2014Q2 us-gaap Other Inventory
OtherInventory
141345 USD
CY2013Q4 us-gaap Other Inventory
OtherInventory
51364 USD
CY2013Q4 us-gaap Cash
Cash
3551832 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
171563 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
64117 USD
CY2013Q4 us-gaap Assets
Assets
5078831 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
78915 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
76109 USD
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
149341 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66739 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
100000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
333519 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
294898 USD
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2013Q4 us-gaap Liabilities
Liabilities
294898 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
89238 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
84238 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34113436 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20096991 USD
CY2014Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
17170951 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
15397296 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
17031723 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
4783933 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17365242 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5078831 USD
CY2014Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
78915 USD
CY2013Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
76109 USD
CY2014Q2 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
43277 USD
CY2014Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
15250 USD
bpth Firm Owes Facility Expenses
FirmOwesFacilityExpenses
3213 USD
CY2012Q3 bpth Stock Issued During Period Shares Contingent Considerations
StockIssuedDuringPeriodSharesContingentConsiderations
50000 shares
CY2008Q2 bpth Fair Value Of Common Stock Issued
FairValueOfCommonStockIssued
180000 USD
CY2008Q4 bpth Fair Value Of Common Stock Issued
FairValueOfCommonStockIssued
40000 USD
CY2008Q2 bpth Common Stock Additional Shares Issued
CommonStockAdditionalSharesIssued
24 shares
CY2012Q3 bpth Issuance Of Common Stock Shares For Service
IssuanceOfCommonStockSharesForService
18500 shares
CY2014Q1 bpth Issuance Of Common Stock And Warrants Shares
IssuanceOfCommonStockAndWarrantsShares
5000000 shares
CY2014Q1 bpth Common Stock Repurchased Shares
CommonStockRepurchasedShares
2500000 shares
CY2014Q1 bpth Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
15000000 USD
CY2011Q4 bpth Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
1920000 shares
CY2011Q4 bpth Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
576000 USD
CY2012Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
795001 USD
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
489501 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89237872 shares
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
122793 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
75000 USD
CY2014Q2 bpth Accrued Patent Expense Current
AccruedPatentExpenseCurrent
25000 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
50000 USD
bpth Drug Product Testing Agreement Consideration To Be Paid In Stages
DrugProductTestingAgreementConsiderationToBePaidInStages
370000 USD
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84237872 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84237872 shares
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2013Q2 us-gaap Revenues
Revenues
0 USD
CY2014Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
557135 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
624681 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156036 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
517040 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6469166 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
480354 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1135400 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
240543 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
754548 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9829509 USD
us-gaap Operating Expenses
OperatingExpenses
1084556 USD
us-gaap Operating Expenses
OperatingExpenses
1785012 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
428646 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
1274801 USD
us-gaap Operating Expenses
OperatingExpenses
17502932 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1084556 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1785012 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-428646 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1274801 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17502932 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1655 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
11639 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1531 USD
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
6066 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
92766 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2013Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2014Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
244479 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
345 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
281 USD
CY2013Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
129 USD
CY2014Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
42 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5264 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1310 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11358 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1402 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6024 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
331981 USD
us-gaap Net Income Loss
NetIncomeLoss
-1083246 USD
us-gaap Net Income Loss
NetIncomeLoss
-1773654 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-427244 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1268777 USD
us-gaap Net Income Loss
NetIncomeLoss
-17170951 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64412577 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89237872 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66606105 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89237872 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52592648 shares
us-gaap Adjustment For Amortization
AdjustmentForAmortization
80312 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
80312 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1217670 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
690000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
318500 USD
us-gaap Share Based Compensation
ShareBasedCompensation
29557 USD
us-gaap Share Based Compensation
ShareBasedCompensation
209071 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3927304 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
84180 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
89981 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
141345 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3836 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
107446 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
171563 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-61388 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
38621 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
333519 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1122781 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1643077 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10996866 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
884710 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-884710 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
435000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
15000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2515961 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13812373 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27182704 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2515961 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13812373 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
27602704 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1393180 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
12169296 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
15721128 USD
CY2012Q4 us-gaap Cash
Cash
534046 USD
CY2007Q2 us-gaap Cash
Cash
0 USD
CY2013Q2 us-gaap Cash
Cash
1927226 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
445 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
420000 USD
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.74
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
BIO-PATH HOLDINGS INC
dei Entity Central Index Key
EntityCentralIndexKey
0001133818
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
BPTH
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
89237872 shares

Files In Submission

Name View Source Status
0001144204-14-050058-index-headers.html Edgar Link pending
0001144204-14-050058-index.html Edgar Link pending
0001144204-14-050058.txt Edgar Link pending
0001144204-14-050058-xbrl.zip Edgar Link pending
bpth-20140630.xml Edgar Link completed
bpth-20140630.xsd Edgar Link pending
bpth-20140630_cal.xml Edgar Link unprocessable
bpth-20140630_def.xml Edgar Link unprocessable
bpth-20140630_lab.xml Edgar Link unprocessable
bpth-20140630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v386337_10q.htm Edgar Link pending
v386337_ex31.htm Edgar Link pending
v386337_ex32.htm Edgar Link pending